Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

19.62USD
25 Mar 2019
Change (% chg)

-- (--)
Prev Close
$19.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
313,150
52-wk High
$32.32
52-wk Low
$9.87

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -4.18 -- --
ROI: -49.45 8.89 13.82
ROE: -52.35 10.02 15.24

Earnings vs. Estimates